| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,281 |
4,985 |
$589K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,218 |
1,858 |
$164K |
| 99215 |
Prolong outpt/office vis |
1,256 |
1,006 |
$162K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
298 |
265 |
$35K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
318 |
276 |
$35K |
| 92587 |
|
1,742 |
1,471 |
$34K |
| 94760 |
|
6,284 |
5,124 |
$16K |
| 93000 |
|
986 |
874 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
833 |
457 |
$10K |
| 90682 |
|
119 |
108 |
$6K |
| 92567 |
|
350 |
314 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
404 |
235 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
31 |
31 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
407 |
290 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
12 |
$1K |
| 90686 |
|
65 |
47 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
32 |
15 |
$841.80 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
394 |
203 |
$547.90 |
| 90656 |
|
17 |
14 |
$296.70 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
34 |
15 |
$150.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$144.54 |
| 81002 |
|
18 |
15 |
$27.70 |